0001104659-24-084069.txt : 20240730
0001104659-24-084069.hdr.sgml : 20240730
20240730194938
ACCESSION NUMBER: 0001104659-24-084069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240726
FILED AS OF DATE: 20240730
DATE AS OF CHANGE: 20240730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MALIK NAVID
CENTRAL INDEX KEY: 0001629113
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35737
FILM NUMBER: 241159485
MAIL ADDRESS:
STREET 1: 1 CHOLMELEY PARK
STREET 2: HIGHGATE
CITY: LONDON
STATE: X0
ZIP: N6 5ET
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC
CENTRAL INDEX KEY: 0001072379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943306718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (240) 497-9024
MAIL ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
tm2420472-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-07-26
0
0001072379
NORTHWEST BIOTHERAPEUTICS INC
NWBO
0001629113
MALIK NAVID
C/O NORTHWEST BIOTHERAPEUTICS, INC.
48 MONTGOMERY LANE, SUITE 800
BETHESDA
MD
20814
1
0
0
0
0
Stock Option
0.23
2024-07-26
4
S
0
657895
0.38
D
2018-05-28
2028-05-28
Common Stock
657895
23339393
D
*Mr. Malik sold 657,895 common stock options to Mr. Jerry Jasinowski, former director of Northwest Biotherapeutics, Inc.
/s/ Navid Malik
2024-07-30